JP2019508397A5 - - Google Patents

Download PDF

Info

Publication number
JP2019508397A5
JP2019508397A5 JP2018540114A JP2018540114A JP2019508397A5 JP 2019508397 A5 JP2019508397 A5 JP 2019508397A5 JP 2018540114 A JP2018540114 A JP 2018540114A JP 2018540114 A JP2018540114 A JP 2018540114A JP 2019508397 A5 JP2019508397 A5 JP 2019508397A5
Authority
JP
Japan
Prior art keywords
improved
compound
group
independently selected
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018540114A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019508397A (ja
JP7022069B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/016494 external-priority patent/WO2017136717A1/en
Publication of JP2019508397A publication Critical patent/JP2019508397A/ja
Publication of JP2019508397A5 publication Critical patent/JP2019508397A5/ja
Application granted granted Critical
Publication of JP7022069B2 publication Critical patent/JP7022069B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018540114A 2016-02-04 2017-02-03 ラパドシン(Rapadocins)、受動拡散型ヌクレオシド輸送体1阻害剤及びその使用 Active JP7022069B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662291428P 2016-02-04 2016-02-04
US62/291,428 2016-02-04
PCT/US2017/016494 WO2017136717A1 (en) 2016-02-04 2017-02-03 Rapadocins, inhibitors of equilibrative nucleoside transporter 1 and uses thereof

Publications (3)

Publication Number Publication Date
JP2019508397A JP2019508397A (ja) 2019-03-28
JP2019508397A5 true JP2019508397A5 (cg-RX-API-DMAC7.html) 2020-02-13
JP7022069B2 JP7022069B2 (ja) 2022-02-17

Family

ID=59500022

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018540114A Active JP7022069B2 (ja) 2016-02-04 2017-02-03 ラパドシン(Rapadocins)、受動拡散型ヌクレオシド輸送体1阻害剤及びその使用

Country Status (9)

Country Link
US (2) US10774110B2 (cg-RX-API-DMAC7.html)
EP (2) EP3411032B1 (cg-RX-API-DMAC7.html)
JP (1) JP7022069B2 (cg-RX-API-DMAC7.html)
CN (2) CN108697701B (cg-RX-API-DMAC7.html)
AU (1) AU2017214557B2 (cg-RX-API-DMAC7.html)
CA (1) CA3013650A1 (cg-RX-API-DMAC7.html)
ES (1) ES2837484T3 (cg-RX-API-DMAC7.html)
MX (2) MX380313B (cg-RX-API-DMAC7.html)
WO (1) WO2017136717A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108697729B (zh) 2016-02-04 2023-05-09 约翰霍普金斯大学 新型GLUT抑制剂rapaglutin及其用途
US11066416B2 (en) 2016-02-04 2021-07-20 The Johns Hopkins University Rapafucin derivative compounds and methods of use thereof
AU2017214557B2 (en) * 2016-02-04 2022-05-19 The Johns Hopkins University Rapadocins, inhibitors of equilibrative nucleoside transporter 1 and uses thereof
TW202126323A (zh) 2019-10-01 2021-07-16 約翰斯赫普金斯大學 雷帕弗辛(Rapafucin)衍生化合物及其使用方法
MX2022012558A (es) * 2020-04-07 2023-02-22 iTeos Belgium SA Derivados de diaminas macrocíclicas como inhibidores de ent para el tratamiento de cánceres y combinación de estos con antagonistas del receptor de adenosina.
EP4413003A1 (en) * 2021-10-06 2024-08-14 iTeos Belgium SA Processes for preparing a macrocyclic compound having ent1 inhibiting activity
EP4413004A1 (en) * 2021-10-06 2024-08-14 iTeos Belgium SA Macrocyclic compounds having ent1 inhibiting activity

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5100899A (en) * 1989-06-06 1992-03-31 Roy Calne Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof
US5457194A (en) * 1993-03-17 1995-10-10 Abbott Laboratories Substituted aliphatic amine-containing macrocyclic immunomodulators
US5798355A (en) 1995-06-07 1998-08-25 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity
US5527907A (en) 1993-11-19 1996-06-18 Abbott Laboratories Macrolide immunomodulators
US5696135A (en) 1995-06-07 1997-12-09 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth
US7056935B2 (en) 1995-06-07 2006-06-06 Gpi Nil Holdings, Inc. Rotamase enzyme activity inhibitors
US6984635B1 (en) 1998-02-13 2006-01-10 Board Of Trustees Of The Leland Stanford Jr. University Dimerizing agents, their production and use
EP1352910A1 (en) 2002-04-10 2003-10-15 Grünenthal GmbH New analogs of nitrobenzylthioinosine
GB0228723D0 (en) * 2002-12-09 2003-01-15 Cambridge Biotechnology Ltd Treatment of pain
WO2004093798A2 (en) 2003-04-18 2004-11-04 Enanta Pharmaceuticals, Inc. Quinoxalinyl macrocyclic hepatitis c serine protease inhibitors
US20060003362A1 (en) * 2004-06-04 2006-01-05 Xenoport, Inc. ENT1 transporters expressed in cancer cells
GB0417852D0 (en) 2004-08-11 2004-09-15 Biotica Tech Ltd Production of polyketides and other natural products
JP2009513135A (ja) 2005-10-28 2009-04-02 プリーシス・ファーマシューティカルズ・インコーポレイテッド エンコードされたライブラリーを用いて興味のある化合物を同定する方法
US20080306098A1 (en) 2006-11-06 2008-12-11 Mutz Mitchell W Pharmacokinetics of protease inhibitors and other drugs
EP3417859A1 (en) 2007-03-07 2018-12-26 Abraxis BioScience, LLC Nanoparticle comprising rapamycin and albumin as anticancer agent
JP2010527618A (ja) 2007-05-24 2010-08-19 アメリカ合衆国 ヌクレオシドサルベージ経路を通しての核内タンパク質伝達
WO2010004304A1 (en) 2008-06-17 2010-01-14 Biotica Technology Limited Novel compounds and methods for their production
AU2011336727B2 (en) * 2010-11-30 2016-11-03 The Johns Hopkins University Hybrid cyclic libraries and screens thereof
WO2012106702A2 (en) 2011-02-04 2012-08-09 The General Hospital Corporation Treatment of leukemia
EP2607352A1 (en) 2011-12-22 2013-06-26 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Pipecolate-diketoamides for treatment of psychiatric disorders
KR101733736B1 (ko) 2012-01-06 2017-05-10 삼성에스디아이 주식회사 리튬 이차 전지용 음극 활물질, 그 제조 방법 및 이를 포함하는 리튬 이차 전지
WO2014008636A1 (en) 2012-07-11 2014-01-16 Merck Sharp & Dohme Corp. Macrocyclic compounds as hiv integrase inhibitors
US10167259B2 (en) 2013-06-14 2019-01-01 The Board Of Regents Of The University Of Texas System Allosteric inhibitors of proteasome and methods of use thereof
WO2016112295A1 (en) 2015-01-09 2016-07-14 Warp Drive Bio, Inc. Compounds that participate in cooperative binding and uses thereof
CA3000822A1 (en) 2015-10-01 2017-04-06 Warp Drive Bio, Inc. Methods and reagents for analyzing protein-protein interfaces
WO2017136708A1 (en) * 2016-02-04 2017-08-10 The Johns Hopkins University Synthesis and composition of rapafucin libraries
CN108697729B (zh) * 2016-02-04 2023-05-09 约翰霍普金斯大学 新型GLUT抑制剂rapaglutin及其用途
US11066416B2 (en) 2016-02-04 2021-07-20 The Johns Hopkins University Rapafucin derivative compounds and methods of use thereof
AU2017214557B2 (en) * 2016-02-04 2022-05-19 The Johns Hopkins University Rapadocins, inhibitors of equilibrative nucleoside transporter 1 and uses thereof
CR20180499A (es) 2016-04-22 2019-01-25 Astrazeneca Ab Inhibidores de mcl1 macrocicliclos para tratar el cancer
US20190224274A1 (en) 2016-09-02 2019-07-25 The Johns Hopkins University Mif inhibitors and methods of use thereof
UY37900A (es) 2017-09-26 2019-04-30 Novartis Ag Nuevos derivados de rapamicina

Similar Documents

Publication Publication Date Title
JP2015503527A5 (cg-RX-API-DMAC7.html)
WO2020150417A3 (en) Compounds and compositions for treating conditions associated with sting activity
JP2013537907A5 (cg-RX-API-DMAC7.html)
JP2004534850A5 (cg-RX-API-DMAC7.html)
JP2005531553A5 (cg-RX-API-DMAC7.html)
AU2017209925B2 (en) Aryl substituted pyrimidines for use in influenza virus infection
RU2016141934A (ru) Ингибиторы циклин-зависимой киназы 7 (cdk7)
JP2014520767A5 (cg-RX-API-DMAC7.html)
JP2010529208A5 (cg-RX-API-DMAC7.html)
JP2014510148A5 (cg-RX-API-DMAC7.html)
DK2298768T3 (da) 5-Amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2H-pyrido[2,3-d]pyrimidinderivater og beslægtede forbindelser til behandling af cancer
JP2017527532A5 (cg-RX-API-DMAC7.html)
JP2015520767A5 (cg-RX-API-DMAC7.html)
CN108697701B (zh) 平衡型核苷转运蛋白1的抑制剂Rapadocin及其用途
JP2016531842A5 (cg-RX-API-DMAC7.html)
JP2004518723A5 (cg-RX-API-DMAC7.html)
JP2014530866A5 (cg-RX-API-DMAC7.html)
RU2019121667A (ru) Аминопиразолы в качестве селективных ингибиторов янус-киназы
JP2014527040A5 (cg-RX-API-DMAC7.html)
JP2013526559A5 (cg-RX-API-DMAC7.html)
PT1942108E (pt) Composto com um grupo básico e a sua utilização
JP2016531846A5 (cg-RX-API-DMAC7.html)
RU2015116532A (ru) Ингибиторы тирозинкиназы syk
JP2010537994A5 (cg-RX-API-DMAC7.html)
CN115867545A8 (zh) 抗病毒素1,3-二氧代茚化合物